Navigation Links
Discovery of natural antibody brings a universal flu vaccine a step closer
Date:7/7/2011

uses in lab-dish tests and in mice. The affected viruses include H3 and H7, two subtypes of great concern for human health that have already caused a pandemic (H3) or sporadic human infections (H7).

As with the CR6261 project, Ekiert and colleagues were able to grow crystals of the new antibody bound to an HA protein from a deadly strain of H3N2, and to use X-ray crystallography techniques to determine the antibody's structure and its precise epitope on the viral HA protein.

"It's even lower on the HA stalk than the CR6261 epitope; in fact it's closer to the viral envelope than any other influenza antibody epitope we've ever seen," said Ekiert.

Crucell is about to begin initial clinical trials of CR6261 in human volunteers, and the company expects eventually to begin similar trials of CR8020. If those trials succeed, aside from a vaccine the two antibodies could be combined and used in a "passive immunotherapy" approach. "This would mainly be useful as a fast-acting therapy against epidemic or pandemic influenza viruses," said Wilson. "The ultimate goal is an active vaccine that elicits a robust, long-term antibody response against those vulnerable epitopes; but developing that is going to be a challenging task."


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Life Sciences Discovery Fund helps launch 3 programs to advance health research and development
2. Trudeau Institute announces new discovery in battle against plague and bacterial pneumonias
3. UC Riverside neuroscientists discovery could bring relief to epilepsy sufferers
4. New discovery -- copepods share divers weight belt technique with whales
5. Cancer protein discovery may aid radiation therapy
6. Quantum sensor tracked in human cells could aid drug discovery
7. Discovery of canine hepatitis C virus opens up new doors for research on deadly human pathogen
8. Social network helps in discovery of a species of plant lice for the first time in Europe
9. Discovery of DNA silencing mechanism reveals how plants protect their genome
10. Serendipity leads to lifesaving discovery
11. Discovery demonstrates potential MS therapy could kill brain cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2015)... As the digital payment services ... advanced biometrics technology is accelerating beyond expectations.  While the ... using their credit cards, the digital currency, mobile payment ... services led by companies in the space such as ... (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ...
(Date:8/10/2015)... TELTOW, Germany , August 10, 2015 ... a world leader in Eye Tracking Technology for more ... OEM Eye Tracking Platform for integration into all consumer ... reference designs for seamless integration of eye tracking into ... HMDs and augmented reality smart glasses. Omnivision,s leading sensor ...
(Date:8/6/2015)... SAN JOSE, Calif. , Aug. 6, 2015 ... the leading developer of human interface solutions, today ... and TouchPad technologies on Windows 10. Microsoft leveraged ... fundamental to the operating system. ... and drivers are fully certified with Microsoft,s Precision ...
Breaking Biology News(10 mins):Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... tools and techniques for achieving targeted gene delivery and ... the successful application of gene therapy to treat a ... are presented in a series of five provocative articles ... , a peer-reviewed journal published by Mary Ann Liebert, ...
... gold standard for medical-use nanoparticles. A new paper* ... Technology (NIST) and the National Cancer Institute,s Nanotechnology Characterization ... nanoparticle "testbed" to explore how the tiny particles behave ... to characterize nanoparticle formulations to determine just what you,re ...
... freshwater cichlids in the western branch of the East ... thriving ecosystem around Lake Kivu. Natural hazards and ... Rwanda and the Democratic Republic of Congo have compromised ... forests for fuel use and subsistence farming has claimed ...
Cached Biology News:The promise of stem cell-based gene therapy 2Branch offices: New family of gold-based nanoparticles could serve as biomedical 'testbed' 2Benchmarking a slice of Africa; preserving biodiversity through science 2Benchmarking a slice of Africa; preserving biodiversity through science 3Benchmarking a slice of Africa; preserving biodiversity through science 4Benchmarking a slice of Africa; preserving biodiversity through science 5
(Date:8/27/2015)... MA (PRWEB) , ... August 27, 2015 , ... Inc. ... United States, ranking iLab Solutions as number 1,361 in growth for the three years ... of the top 0.1% fastest-growing privately held organizations in the country. , “We ...
(Date:8/26/2015)... Aug. 26, 2015 /PRNewswire/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended June 30, ... Canadian dollars and presented under International Financial Reporting ... with respect to our Oral Amp B program, ... manufacturer," said Andrew Rae , President & ...
(Date:8/26/2015)... , Aug. 26, 2015 Intrexon Corporation ... announced today the closing of its previously announced public ... by the underwriters of their option to purchase an ... offering price of $41.00 per share.  The exercise of ... of common stock sold by Intrexon to 5,609,756 shares ...
(Date:8/26/2015)... Bruno, CA. (PRWEB) , ... August 26, 2015 , ... ... major conferences to develop new business relationships with local sponsors in southern California. The ... to facilitate their drug development processes and regulatory pathways., , ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
... is available in Spanish . , U.S. ... site where the virus that causes foot-and-mouth disease (FMD) ... to development of new vaccines to control and potentially ... disease of cloven-hoofed animals that is considered the most ...
... Reportlinker.com announces that a new market research report is ... and Global Markets http://www.reportlinker.com/p0341184/Nanobiotechnology-Applications-and-Global-Markets.html ... is $19.3 billion in 2010 and is growing at ... reach a forecast market size of $29.7 billion by ...
... Inc., a biopharmaceutical company developing novel therapies to treat ... today announced that it has initiated a Phase 1 ... pharmacodynamic profiles of TRX518, a monoclonal antibody designed to ... more effectively attack cancer cells.   The ...
Cached Biology Technology:USDA scientists discover how foot-and-mouth disease virus begins infection in cattle 2Reportlinker Adds Nanobiotechnology: Applications and Global Markets 2Reportlinker Adds Nanobiotechnology: Applications and Global Markets 3Reportlinker Adds Nanobiotechnology: Applications and Global Markets 4Reportlinker Adds Nanobiotechnology: Applications and Global Markets 5Reportlinker Adds Nanobiotechnology: Applications and Global Markets 6Reportlinker Adds Nanobiotechnology: Applications and Global Markets 7Reportlinker Adds Nanobiotechnology: Applications and Global Markets 8Reportlinker Adds Nanobiotechnology: Applications and Global Markets 9Reportlinker Adds Nanobiotechnology: Applications and Global Markets 10Reportlinker Adds Nanobiotechnology: Applications and Global Markets 11Reportlinker Adds Nanobiotechnology: Applications and Global Markets 12Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 2Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 3
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
...
Bovine Serum...
Healthy animals 10-32 weeks of age, mixed gender and breed; collected on wet ice following USDA guidelines, using Alsevers solution at 1:2 dilution...
Biology Products: